Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 876-884

  Rowe, Jared H ^a   Ertelt, James M ^a   Way, Sing Sing ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 12; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; INNATE IMMUNITY; INTERFERON PRODUCTION; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD274; CD8-POSITIVE T-LYMPHOCYTES; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-12; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERFERON; T-LYMPHOCYTE SUBSETS;

EID: 84863612654     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103227     Document Type: Article

References (69)

1. Keir, M. E., L. M. Francisco, and A. H. Sharpe. 2007. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19: 309-314. (Pubitemid 46687017)
2. Sharpe, A. H., E. J.Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245. (Pubitemid 46745373)
3. Brown, K. E., G. J. Freeman, E. J. Wherry, and A. H. Sharpe. 2010. Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 22: 397-401.
4. Odorizzi, P. M., and E. J. Wherry. 2012. Inhibitory receptors on lymphocytes: insights from infections. J. Immunol. 188: 2957-2965.
5. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
6. Ha, S. J., S. N. Mueller, E. J. Wherry, D. L. Barber, R. D. Aubert, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2008. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J. Exp. Med. 205: 543-555. (Pubitemid 351439302)
7. Maier, H., M. Isogawa, G. J. Freeman, and F. V. Chisari. 2007. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+T lymphocytes in the liver. J. Immunol. 178: 2714-2720. (Pubitemid 46333147)
8. Jun, H., S. K. Seo, H. Y. Jeong, H. M. Seo, G. Zhu, L. Chen, and I. H. Choi. 2005. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Lett. 579: 6259-6264. (Pubitemid 41546277)
9. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403. (Pubitemid 44706581)
10. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
11. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
12. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
13. Lafon, M., F. Mégret, S. G. Meuth, O. Simon, M. L. Velandia Romero, M. Lafage, L. Chen, L. Alexopoulou, R. A. Flavell, C. Prehaud, et al. 2008. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J. Immunol. 180: 7506-7515.
14. Seo, S. K., H. Y. Jeong, S. G. Park, S. W. Lee, I. W. Choi, L. Chen, and I. Choi. 2008. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection. Immunology 123: 90-99. (Pubitemid 350256000)
15. Rowe, J. H., T. M. Johanns, J. M. Ertelt, and S. S. Way. 2008. PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. J. Immunol. 180: 7553-7557.
16. Barber, D. L., K. D. Mayer-Barber, C. G. Feng, A. H. Sharpe, and A. Sher. 2011. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186: 1598-1607.
17. Lázár-Molnár, E., B. Chen, K. A. Sweeney, E. J. Wang, W. Liu, J. Lin, S. A. Porcelli, S. C. Almo, S. G. Nathenson, and W. R. Jacobs, Jr. 2010. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. USA 107: 13402-13407.
18. Lee, S. J., H. O'Donnell, and S. J. McSorley. 2010. B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection. J. Immunol. 185: 2442-2449.
19. hi CD8 T cells in healthy human adults. J. Immunol. 186: 4200-4212.
20. Boasso, A., A. W. Hardy, A. L. Landay, J. L. Martinson, S. A. Anderson, M. J. Dolan, M. Clerici, and G. M. Shearer. 2008. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin. Immunol. 129: 132-144.
21. Ma, C. J., L. Ni, Y. Zhang, C. L. Zhang, X. Y. Wu, A. N. Atia, P. Thayer, J. P. Moorman, and Z. Q. Yao. 2011. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology 132: 421-431.
22. Schreiner, B., M. Mitsdoerffer, B. C. Kieseier, L. Chen, H. P. Hartung, M. Weller, and H. Wiendl. 2004. Interferon-b enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155: 172-182. (Pubitemid 39165790)
23. Zhang, Y., C. J. Ma, L. Ni, C. L. Zhang, X. Y. Wu, U. Kumaraguru, C. F. Li, J. P. Moorman, and Z. Q. Yao. 2011. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection. J. Immunol. 186: 3093-3103.
24. O'Connell, R. M., S. K. Saha, S. A. Vaidya, K. W. Bruhn, G. A. Miranda, B. Zarnegar, A. K. Perry, B. O. Nguyen, T. F. Lane, T. Taniguchi, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200: 437-445. (Pubitemid 39121901)
25. O'Riordan, M., C. H. Yi, R. Gonzales, K. D. Lee, and D. A. Portnoy. 2002. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. USA 99: 13861-13866. (Pubitemid 35215471)
26. Way, S. S., C. Havenar-Daughton, G. A. Kolumam, N. N. Orgun, and K. Murali- Krishna. 2007. IL-12 and type-I IFN synergize for IFN-γ production by CD4 T cells, whereas neither are required for IFN-γ production by CD8 T cells after Listeria monocytogenes infection. J. Immunol. 178: 4498-4505. (Pubitemid 46492402)
27. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189: 1315-1328.
28. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
29. Wu, C., J. Ferrante, M. K. Gately, and J. Magram. 1997. Characterization of IL-12 receptor b1 chain (IL-12Rb1)-deficient mice: IL-12Rb1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159: 1658-1665. (Pubitemid 127484149)
30. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-g receptor. Science 259: 1742-1745. (Pubitemid 23114659)
31. Nishimura, H., N. Minato, T. Nakano, and T. Honjo. 1998. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10: 1563-1572. (Pubitemid 28451451)
32. Xiao, Z., K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 182: 2786-2794.
33. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27. (Pubitemid 24035278)
34. Foulds, K. E., L. A. Zenewicz, D. J. Shedlock, J. Jiang, A. E. Troy, and H. Shen. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168: 1528-1532. (Pubitemid 34135743)
35. Orgun, N. N., M. A. Mathis, C. B. Wilson, and S. S. Way. 2008. Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells. J. Immunol. 180: 4109-4115.
36. Auerbuch, V., D. G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D. A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200: 527-533. (Pubitemid 39121909)
37. Carrero, J. A., B. Calderon, and E. R. Unanue. 2004. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200: 535-540. (Pubitemid 39121910)
38. Brombacher, F., A. Dorfmüller, J. Magram, W. J. Dai, G. Köhler, A. Wunderlin, K. Palmer-Lehmann, M. K. Gately, and G. Alber. 1999. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11: 325-332. (Pubitemid 29121619)
39. Pearce, E. L., and H. Shen. 2007. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 179: 2074-2081.
40. Harty, J. T., and M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN g. Immunity 3: 109-117.
41. + T-cell IL-17 production. Immunology 131: 183-191.
42. Pulko, V., K. J. Harris, X. Liu, R. M. Gibbons, S. M. Harrington, C. J. Krco, E. D. Kwon, and H. Dong. 2011. B7-h1 expressed by activated CD8 T cells is essential for their survival. J. Immunol. 187: 5606-5614.
43. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
44. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
45. Carrero, J. A., B. Calderon, and E. R. Unanue. 2006. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203: 933-940.
46. Curtsinger, J. M., and M. F. Mescher. 2010. Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol. 22: 333-340.
47. + T cell response. Immunity 25: 19-29.
48. Lieberman, L. A., and C. A. Hunter. 2002. Regulatory pathways involved in the infection-induced production of IFN-γ by NK cells. Microbes Infect. 4: 1531-1538. (Pubitemid 36050822)
49. Nomura, T., I. Kawamura, K. Tsuchiya, C. Kohda, H. Baba, Y. Ito, T. Kimoto, I. Watanabe, and M. Mitsuyama. 2002. Essential role of interleukin-12 (IL-12) and IL-18 for γ interferon production induced by listeriolysin O in mouse spleen cells. Infect. Immun. 70: 1049-1055. (Pubitemid 34163373)
50. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4: 471-481. (Pubitemid 26354656)
51. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
52. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J. Exp. Med. 204: 1803-1812.
53. Rubinstein, M. P., M. Kovar, J. F. Purton, J. H. Cho, O. Boyman, C. D. Surh, and J. Sprent. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Rα. Proc. Natl. Acad. Sci. USA 103: 9166-9171. (Pubitemid 43902550)
54. Whitmire, J. K., N. Benning, and J. L. Whitton. 2005. Cutting edge: early IFN-γsignaling directly enhances primary antiviral CD4+ T cell responses. J. Immunol. 175: 5624-5628. (Pubitemid 41508043)
55. + T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
56. Sercan, O., G. J. Hämmerling, B. Arnold, and T. Schüler. 2006. Innate immune cells contribute to the IFN-γ-dependent regulation of antigen-specific CD8+T cell homeostasis. J. Immunol. 176: 735-739. (Pubitemid 43099669)
57. + T cell differentiation. J. Immunol. 184: 2855-2862.
58. Reiley, W. W., S. Shafiani, S. T. Wittmer, G. Tucker-Heard, J. J. Moon, M. K. Jenkins, K. B. Urdahl, G. M.Winslow, and D. L.Woodland. 2010. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 107: 19408-19413.
59. + T cell proliferation by augmenting IFN-γ-induced nitric oxide production. J. Immunol. 175: 1586-1592.
60. Beckerman, K. P., H. W. Rogers, J. A. Corbett, R. D. Schreiber, M. L. McDaniel, and E. R. Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150: 888-895. (Pubitemid 23133668)
61. Boockvar, K. S., D. L. Granger, R. M. Poston, M. Maybodi, M. K. Washington, J. B. Hibbs, Jr., and R. L. Kurlander. 1994. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62: 1089-1100. (Pubitemid 24065600)
62. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254. (Pubitemid 23344886)
63. +TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156: 3321-3326.
64. + T cell responses during chronic infection. Nat. Immunol. 12: 663-671.
65. Ou, R., S. Zhou, L. Huang, and D. Moskophidis. 2001. Critical role for α/β and γ interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75: 8407-8423. (Pubitemid 32768945)
66. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178: 1435-1440. (Pubitemid 23277375)
67. Sakai, S., I. Kawamura, T. Okazaki, K. Tsuchiya, R. Uchiyama, and M. Mitsuyama. 2010. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin. Int. Immunol. 22: 915-925.
68. + T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. USA 108: 9196-9201.
69. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.